BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Houghton J, Wang TC. Helicobacter pylori and Gastric Cancer: A New Paradigm For Inflammation-Associated Epithelial Cancers. Gastroenterology 2005;128:1567-78. [DOI: 10.1053/j.gastro.2005.03.037] [Cited by in Crossref: 171] [Cited by in F6Publishing: 168] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Ma YY, Tao HQ. Role of urokinase plasminogen activator receptor in gastric cancer: a potential therapeutic target. Cancer Biother Radiopharm 2012;27:285-90. [PMID: 22702495 DOI: 10.1089/cbr.2012.1232] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Sahingur SE, Yeudall WA. Chemokine function in periodontal disease and oral cavity cancer. Front Immunol 2015;6:214. [PMID: 25999952 DOI: 10.3389/fimmu.2015.00214] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 10.0] [Reference Citation Analysis]
3 Zhao C, Lu X, Bu X, Zhang N, Wang W. Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. BMC Cancer 2010;10:419. [PMID: 20699000 DOI: 10.1186/1471-2407-10-419] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhao X, Kang S, Liu L, Zhang D. Correlation of Asp299Gly and Thr399Ile polymorphisms in toll-like receptor 4 gene with digestive cancer risk: A meta-analysis. Biomed Rep 2013;1:294-302. [PMID: 24648938 DOI: 10.3892/br.2012.32] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Wang J, Lin C, Li H, Li R, Wu Y, Liu H, Zhang H, He H, Zhang W, Xu J. Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer. Oncoimmunology 2017;6:e1353858. [PMID: 29147601 DOI: 10.1080/2162402X.2017.1353858] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alison MR, Lim S, Houghton JM. Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship. Curr Opin Oncol 2009;21:77-82. [PMID: 19125022 DOI: 10.1097/CCO.0b013e32831de4cf] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Shiotani A, Haruma K, Graham DY. Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol. 2014;20:11552-11559. [PMID: 25206262 DOI: 10.3748/wjg.v20.i33.11522] [Reference Citation Analysis]
8 Yousuf A, Bhat MY, Pandith AA, Afroze D, Khan NP, Alam K, Shah P, Shah MA, Mudassar S. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell Oncol (Dordr). 2014;37:245-252. [PMID: 25008999 DOI: 10.1007/s13402-014-0179-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
9 Thiyagarajan P, Chandrasekaran CV, Deepak HB, Agarwal A. Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents. Inflammopharmacology. 2011;19:235-241. [PMID: 21328091 DOI: 10.1007/s10787-011-0080-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
10 Hansson M, Hermansson M, Svensson H, Elfvin A, Hansson LE, Johnsson E, Sjöling A, Quiding-Järbrink M. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect Immun 2008;76:3304-11. [PMID: 18426876 DOI: 10.1128/IAI.00041-08] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
11 Piscione M, Mazzone M, Di Marcantonio MC, Muraro R, Mincione G. Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship. Front Microbiol 2021;12:630852. [PMID: 33613500 DOI: 10.3389/fmicb.2021.630852] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
12 Worthley DL, Giraud AS, Wang TC. Stromal fibroblasts in digestive cancer. Cancer Microenviron. 2010;3:117-125. [PMID: 21209778 DOI: 10.1007/s12307-009-0033-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
13 Wu DC, Wang KY, Wang SSW, Huang CM, Lee YW, Chen MI, Chuang SA, Chen SH, Lu YW, Lin CC, Lee KW, Hsu WH, Wu KP, Chen YJ. Exploring the expression bar code of SAA variants for gastric cancer detection. Proteomics. 2017;17. [PMID: 28493537 DOI: 10.1002/pmic.201600356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Mills JC, Shivdasani RA. Gastric epithelial stem cells. Gastroenterology 2011;140:412-24. [PMID: 21144849 DOI: 10.1053/j.gastro.2010.12.001] [Cited by in Crossref: 126] [Cited by in F6Publishing: 101] [Article Influence: 11.5] [Reference Citation Analysis]
15 Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene. 2008;27:234-243. [PMID: 18176605 DOI: 10.1038/sj.onc.1210908] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 9.4] [Reference Citation Analysis]
16 Zhu F, Zhao H, Tian X, Meng X. Association between tumor necrosis factor-α rs1800629 polymorphism and risk of gastric cancer: a meta-analysis. Tumour Biol. 2014;35:1799-1803. [PMID: 24142527 DOI: 10.1007/s13277-013-1240-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
17 Alison MR, Lovell MJ, Direkze NC, Wright NA, Poulsom R. Stem cell plasticity and tumour formation. Eur J Cancer 2006;42:1247-56. [PMID: 16632345 DOI: 10.1016/j.ejca.2006.01.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
18 Laszkowska M, Oh A, Hur C. Screening for Upper Gastrointestinal Malignancies in the United States-Which Immigrant Groups Should Be Considered High-Risk? Gastroenterology 2020;158:4-8. [PMID: 31614125 DOI: 10.1053/j.gastro.2019.09.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 He ML, Chen WW, Zhang PJ, Jiang AL, Fan W, Yuan HQ, Liu WW, Zhang JY. Gum mastic increases maspin expression in prostate cancer cells. Acta Pharmacol Sin 2007;28:567-72. [PMID: 17376297 DOI: 10.1111/j.1745-7254.2007.00535.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
20 Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27:1006-1020. [PMID: 19415765 DOI: 10.1002/stem.30] [Cited by in Crossref: 653] [Cited by in F6Publishing: 586] [Article Influence: 54.4] [Reference Citation Analysis]
21 Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol. 2012;2:92. [PMID: 22919683 DOI: 10.3389/fcimb.2012.00092] [Cited by in Crossref: 121] [Cited by in F6Publishing: 108] [Article Influence: 13.4] [Reference Citation Analysis]
22 Tomimori K, Uema E, Teruya H, Ishikawa C, Okudaira T, Senba M, Yamamoto K, Matsuyama T, Kinjo F, Fujita J. Helicobacter pylori induces CCL20 expression. Infect Immun. 2007;75:5223-5232. [PMID: 17724069 DOI: 10.1128/IAI.00731-07] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
23 Huang T, Kang W, Cheng AS, Yu J, To KF. The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers. BMC Cancer. 2015;15:950. [PMID: 26674478 DOI: 10.1186/s12885-015-1984-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
24 Humphries A, Wright NA. Colonic crypt organization and tumorigenesis. Nat Rev Cancer 2008;8:415-24. [PMID: 18480839 DOI: 10.1038/nrc2392] [Cited by in Crossref: 217] [Cited by in F6Publishing: 189] [Article Influence: 16.7] [Reference Citation Analysis]
25 Zhu S, Soutto M, Chen Z, Peng D, Romero-Gallo J, Krishna US, Belkhiri A, Washington MK, Peek R, El-Rifai W. Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32. Gut 2017;66:761-2. [PMID: 27590997 DOI: 10.1136/gutjnl-2016-312141] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
26 Takeshima E, Tomimori K, Takamatsu R, Ishikawa C, Kinjo F, Hirayama T, Fujita J, Mori N. Helicobacter pylori VacA activates NF-kappaB in T cells via the classical but not alternative pathway. Helicobacter. 2009;14:271-279. [PMID: 19674131 DOI: 10.1111/j.1523-5378.2009.00683.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
27 Lanas A, Hunt R. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Ann Med. 2006;38:415-428. [PMID: 17008305 DOI: 10.1080/07853890600925843] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
28 Howlett M, Chalinor HV, Buzzelli JN, Nguyen N, van Driel IR, Bell KM, Fox JG, Dimitriadis E, Menheniott TR, Giraud AS. IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut. 2012;61:1398-1409. [PMID: 22180059 DOI: 10.1136/gutjnl-2011-300539] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
29 Shiotani A, Haruma K, Graham DY. Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol. 2014;20:11552-11559. [PMID: 25206262 DOI: 10.3748/wjg.v20.i33.11552] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
30 Hisatsune J, Yamasaki E, Nakayama M, Shirasaka D, Kurazono H, Katagata Y, Inoue H, Han J, Sap J, Yahiro K. Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells. Infect Immun. 2007;75:4472-4481. [PMID: 17591797 DOI: 10.1128/iai.00500-07] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
31 Durães C, Muñoz X, Bonet C, García N, Venceslá A, Carneiro F, Peleteiro B, Lunet N, Barros H, Lindkvist B, Boutron-ruault M, Bueno-de-mesquita HB, Rizzato C, Trichopoulou A, Weiderpass E, Naccarati A, Travis RC, Tjønneland A, Gurrea AB, Johansson M, Riboli E, Figueiredo C, González CA, Capellà G, Machado JC, Sala N. Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations: IL1A genetic variants in gastric carcinoma. Int J Cancer 2014;135:1343-55. [DOI: 10.1002/ijc.28776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Jeong H, Lee B, Kim KH, Cho SY, Cho Y, Park J, Lee Y, Oh Y, Hwang BR, Jang AR, Park JH, Park JH, Jeong SH, Lee D, Lee YC, Lim KM, Goldenring JR, Nam KT. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury. Gastroenterology 2021;161:953-967.e15. [PMID: 34116028 DOI: 10.1053/j.gastro.2021.05.058] [Reference Citation Analysis]
33 Ubukata H, Motohashi G, Tabuchi T, Nagata H, Konishi S, Tabuchi T. Overt bone metastasis and bone marrow micrometastasis of early gastric cancer. Surg Today 2011;41:169-74. [PMID: 21264750 DOI: 10.1007/s00595-010-4389-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
34 De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9. [PMID: 21483655 DOI: 10.4103/1477-3163.78279] [Cited by in Crossref: 284] [Cited by in F6Publishing: 268] [Article Influence: 28.4] [Reference Citation Analysis]
35 Espinosa-Parrilla Y, Muñoz X, Bonet C, Garcia N, Venceslá A, Yiannakouris N, Naccarati A, Sieri S, Panico S, Huerta JM, Barricarte A, Menéndez V, Sánchez-Cantalejo E, Dorronsoro M, Brennan P, Duarte-Salles T, B As Bueno-de-Mesquita H, Weiderpass E, Lund E, Clavel-Chapelon F, Boutron-Ruault MC, Racine A, Numans ME, Tumino R, Canzian F, Campa D, Sund M, Johansson M, Ohlsson B, Lindkvist B, Overvad K, Tjønneland A, Palli D, Travis RC, Khaw KT, Wareham N, Boeing H, Nesi G, Riboli E, Gonzalez CA, Sala N. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study. Int J Cancer 2014;135:2065-76. [PMID: 24643999 DOI: 10.1002/ijc.28850] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
36 Wright NA. Stem Cells in the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 359-78. [DOI: 10.1016/b978-0-12-382026-6.00012-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy. Helicobacter 2007;12:605-8. [PMID: 18001400 DOI: 10.1111/j.1523-5378.2007.00549.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
38 Wiedemann T, Hofbaur S, Loell E, Rieder G. A C-Terminal Coiled-Coil Region of CagL is Responsible for Helicobacter Pylori-Induced Il-8 Expression. Eur J Microbiol Immunol (Bp) 2016;6:186-96. [PMID: 27766167 DOI: 10.1556/1886.2016.00020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
39 Zhao J, Geng P, Li Z, Cui S, Zhao J, Wang L, Li J, Ji F, Li G, Shen G, Lin M, Shen C. Prostate stem cell antigen rs2294008 polymorphism differentially contributes to Helicobacter pylori-negative gastric cancer among various populations in China. Mol Clin Oncol 2013;1:493-8. [PMID: 24649198 DOI: 10.3892/mco.2013.70] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
40 Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest. 2008;88:328-336. [PMID: 18180700 DOI: 10.1038/labinvest.3700719] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
41 Sureka C, Ramesh T. Molecular assessment of c-H-ras p21 expression in Helicobacter pylori-mediated gastric carcinogenesis. Mol Cell Biochem. 2012;362:169-176. [PMID: 22045063 DOI: 10.1007/s11010-011-1139-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
42 Zou M, Wang F, Jiang A, Xia A, Kong S, Gong C, Zhu M, Zhou X, Zhu J, Zhu W, Cheng W. MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-α, by targeting TRAF3. Helicobacter 2017;22:e12348. [DOI: 10.1111/hel.12348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
43 Hu J, Yu J, Gan J, Song N, Shi L, Liu J, Zhang Z, Du J. Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer. Aging (Albany NY) 2020;12:2595-609. [PMID: 32028262 DOI: 10.18632/aging.102764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
44 Taghizadeh S, Sankian M, Ajami A, Tehrani M, Hafezi N, Mohammadian R, Farazmandfar T, Hosseini V, Abbasi A, Ajami M. Expression levels of vascular endothelial growth factors a and C in patients with peptic ulcers and gastric cancer. J Gastric Cancer 2014;14:196-203. [PMID: 25328765 DOI: 10.5230/jgc.2014.14.3.196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
45 Kim N. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism. J Gastroenterol Hepatol 2019;34:1287-95. [PMID: 30828872 DOI: 10.1111/jgh.14646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
46 Basu PP, Rayapudi K, Pacana T, Shah NJ, Krishnaswamy N, Flynn M. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. Am J Gastroenterol. 2011;106:1970-1975. [PMID: 21989146 DOI: 10.1038/ajg.2011.306] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
47 Zhang X, Tan Z, Kang T, Zhu C, Chen S. Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration. Drug Des Devel Ther 2019;13:3037-49. [PMID: 31692505 DOI: 10.2147/DDDT.S209219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
48 Kalebi A, Rana F, Mwanda W, Lule G, Hale M. Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya. World J Gastroenterol. 2007;13:4117-4121. [PMID: 17696233 DOI: 10.3748/wjg.v13.i30.4117] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
49 Liu Z, Xu X, Chen L, Li W, Sun Y, Zeng J, Yu H, Chen C, Jia J. Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J Cell Biochem 2012;113:1080-6. [DOI: 10.1002/jcb.23440] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
50 Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012;143:35-47.e2. [PMID: 22580099 DOI: 10.1053/j.gastro.2012.05.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 126] [Article Influence: 13.1] [Reference Citation Analysis]
51 Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 2006;131:525-537. [PMID: 16890606 DOI: 10.1053/j.gastro.2006.05.001] [Cited by in Crossref: 194] [Cited by in F6Publishing: 189] [Article Influence: 12.9] [Reference Citation Analysis]
52 Sundquist M, Quiding-Järbrink M. Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies. Expert Rev Gastroenterol Hepatol. 2010;4:733-744. [PMID: 21108593 DOI: 10.1586/egh.10.71] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
53 Wu WK, Sung JJ, Yu L, Li ZJ, Chu KM, Cho CH. Constitutive hypophosphorylation of extracellular signal-regulated kinases-1/2 and down-regulation of c-Jun in human gastric adenocarcinoma. Biochem Biophys Res Commun. 2008;373:330-334. [PMID: 18570890 DOI: 10.1016/j.bbrc.2008.06.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
54 Stec-Michalska K, Peczek L, Krakowiak A, Michalski B, Chojnacki J, Knopik-Dabrowicz A, Klupinska G, Nawrot B. Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer. J Gastroenterol Hepatol. 2008;23:424-429. [PMID: 17683502 DOI: 10.1111/j.1440-1746.2007.05094.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
55 Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63:64-71. [PMID: 24153248 DOI: 10.1136/gutjnl-2013-305033] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
56 Matsueda S, Graham DY. Immunotherapy in gastric cancer. World J Gastroenterol 2014;20:1657-66. [PMID: 24587645 DOI: 10.3748/wjg.v20.i7.1657] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 51] [Article Influence: 8.3] [Reference Citation Analysis]
57 Wu Y, Shen L, Liang X, Li S, Ma L, Zheng L, Li T, Yu H, Chan H, Chen C, Yu J, Jia J. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression. Cancer Med 2019;8:3965-80. [PMID: 31145543 DOI: 10.1002/cam4.2318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
58 Nardone G, Compare D, De Colibus P, de Nucci G, Rocco A. Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Dig Dis. 2007;25:225-229. [PMID: 17827945 DOI: 10.1159/000103890] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
59 Valcz G, Krenács T, Sipos F, Leiszter K, Tóth K, Balogh Z, Csizmadia A, Muzes G, Molnár B, Tulassay Z. The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration. Pathol Oncol Res. 2011;17:11-16. [PMID: 20405350 DOI: 10.1007/s12253-010-9262-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
60 Hung KH, Hung HW, Yang HB, Lu CC, Wu JJ, Sheu BS. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection. Helicobacter 2009;14:580-7. [PMID: 19889076 DOI: 10.1111/j.1523-5378.2009.00717.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
61 Durães C, Almeida GM, Seruca R, Oliveira C, Carneiro F. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch 2014;464:367-78. [DOI: 10.1007/s00428-013-1533-y] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 13.6] [Reference Citation Analysis]
62 Starzyñska T, Malfertheiner P. Helicobacter and digestive malignancies. Helicobacter 2006;11 Suppl 1:32-5. [PMID: 16925609 DOI: 10.1111/j.1478-405X.2006.00431.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
63 Kawazoe T, Sakagami T, Nakajima K, Hori K, Fukuda Y, Matsumoto T, Miwa H. Role of bacterial strain diversity of Helicobacter pylori in gastric carcinogenesis induced by N-methyl-N-nitrosourea in Mongolian gerbils. Helicobacter. 2007;12:213-223. [PMID: 17493001 DOI: 10.1111/j.1523-5378.2007.00491.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
64 Pritchard DM, Crabtree JE. Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol. 2006;22:620-625. [PMID: 17053439 DOI: 10.1097/01.mog.0000245539.50765.f6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
65 Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010;29:5761-5771. [PMID: 20802530 DOI: 10.1038/onc.2010.352] [Cited by in Crossref: 196] [Cited by in F6Publishing: 185] [Article Influence: 17.8] [Reference Citation Analysis]
66 Zhu S, Khalafi S, Chen Z, Poveda J, Peng D, Lu H, Soutto M, Que J, Garcia-Buitrago M, Zaika A, El-Rifai W. Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib. Cancer Lett 2020;491:87-96. [PMID: 32735911 DOI: 10.1016/j.canlet.2020.07.014] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Fitzgerald RC. Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810-1820. [PMID: 17124160 DOI: 10.1136/gut.2005.089144] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 6.6] [Reference Citation Analysis]
68 Gao YW, Xu M, Xu Y, Li D, Zhou S. Effect of three common IL-17 single nucleotide polymorphisms on the risk of developing gastric cancer. Oncol Lett 2015;9:1398-402. [PMID: 25663919 DOI: 10.3892/ol.2014.2827] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
69 Olmez S, Aslan M, Erten R, Sayar S, Bayram I. The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes. Gastroenterol Res Pract. 2015;2015:434039. [PMID: 26635875 DOI: 10.1155/2015/434039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
70 Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol 2017;30:414-23. [PMID: 28655977 DOI: 10.20524/aog.2017.0144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
71 Cai Q, Shi P, Yuan Y, Peng J, Ou X, Zhou W, Li J, Su T, Lin L, Cai S, He Y, Xu J. Inflammation-Associated Senescence Promotes Helicobacter pylori-Induced Atrophic Gastritis. Cell Mol Gastroenterol Hepatol 2021;11:857-80. [PMID: 33161156 DOI: 10.1016/j.jcmgh.2020.10.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
72 Eslick GD. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence. World J Gastroenterol. 2006;12:2991-2999. [PMID: 16718777 DOI: 10.3748/wjg.v12.i19.2991] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
73 Chu A, Liu J, Yuan Y, Gong Y. Comprehensive Analysis of Aberrantly Expressed ceRNA network in gastric cancer with and without H.pylori infection. J Cancer 2019;10:853-63. [PMID: 30854091 DOI: 10.7150/jca.27803] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
74 Quante M, Wang TC. Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology (Bethesda) 2008;23:350-9. [PMID: 19074742 DOI: 10.1152/physiol.00031.2008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
75 Przemeck SM, Varro A, Berry D, Steele I, Wang TC, Dockray GJ, Pritchard DM. Hypergastrinemia increases gastric epithelial susceptibility to apoptosis. Regul Pept 2008;146:147-56. [PMID: 17900712 DOI: 10.1016/j.regpep.2007.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
76 Abbas M, Faggian A, Sintali DN, Khan GJ, Naeem S, Shi M, Dingding C. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018;103:1688-700. [DOI: 10.1016/j.biopha.2018.04.178] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
77 Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X, He F, Wang Y, Zhang Z, Wang W, Wang X, Guo T, Li P, Zhao Y, Ji H, Zhang L, Zhou Z. A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer. Cancer Cell 2014;25:166-80. [DOI: 10.1016/j.ccr.2014.01.010] [Cited by in Crossref: 315] [Cited by in F6Publishing: 292] [Article Influence: 45.0] [Reference Citation Analysis]
78 Zhao L, Lee JY, Hwang DH. Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. Nutr Rev. 2011;69:310-320. [PMID: 21631512 DOI: 10.1111/j.1753-4887.2011.00394.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
79 Rocco A, Compare D, Nardone G. Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions. World J Gastrointest Oncol. 2012;4:54-59. [PMID: 22468184 DOI: 10.4251/wjgo.v4.i3.54] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
80 Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, Fujita Y, Nagamatsu K, Ishijima N, Koyasu S. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe. 2007;2:250-263. [PMID: 18005743 DOI: 10.1016/j.chom.2007.09.005] [Cited by in Crossref: 135] [Cited by in F6Publishing: 135] [Article Influence: 9.6] [Reference Citation Analysis]
81 Pilpilidis I, Kountouras J, Zavos C, Katsinelos P. Upper gastrointestinal carcinogenesis: H. pylori and stem cell cross-talk. J Surg Res. 2011;166:255-264. [PMID: 20452613 DOI: 10.1016/j.jss.2010.02.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
82 Ai W, Takaishi S, Wang TC, Fleming JV. Regulation of l‐Histidine Decarboxylase and Its Role in Carcinogenesis. Elsevier; 2006. pp. 231-70. [DOI: 10.1016/s0079-6603(06)81006-8] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
83 Park DW, Lee KJ, Jin SH, Lee JH, Min JS, Park SH, Yu HJ, Bang HY, Lee JI. Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients. J Gastric Cancer 2010;10:168-74. [PMID: 22076182 DOI: 10.5230/jgc.2010.10.4.168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
84 Hernández C, Toledo-Stuardo K, García-González P, Garrido-Tapia M, Kramm K, Rodríguez-Siza JA, Hermoso M, Ribeiro CH, Molina MC. Heat-killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll-like receptor 4. Helicobacter 2021;26:e12812. [PMID: 33928707 DOI: 10.1111/hel.12812] [Reference Citation Analysis]
85 Murphy A, Kelly RJ. Immunotherapy in upper GI malignancies. Curr Treat Options Oncol. 2015;16:20. [PMID: 25859830 DOI: 10.1007/s11864-015-0336-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
86 Lazăr DC, Avram MF, Romoșan I, Cornianu M, Tăban S, Goldiș A. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World J Gastroenterol 2018;24:3583-616. [PMID: 30166856 DOI: 10.3748/wjg.v24.i32.3583] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
87 Sala N, Muñoz X, Travier N, Agudo A, Duell EJ, Moreno V, Overvad K, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Canzian F, Kaaks R, Boeing H, Meidtner K, Trichopoulos A, Tsiotas K, Zylis D, Vineis P, Panico S, Palli D, Krogh V, Tumino R, Lund E, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Quirós JR, Sánchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Hallmans G, Stenling R, Manjer J, Allen NE, Travis RC, Khaw KT, Jenab M, Offerhaus GJ, Riboli E, González CA. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study. Int J Cancer 2012;130:2417-27. [PMID: 21681742 DOI: 10.1002/ijc.26243] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
88 Wang H, Sun Y, Liu S, Yu H, Li W, Zeng J, Chen C, Jia J. Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration. FEMS Immunol Med Microbiol. 2011;63:82-92. [PMID: 21707777 DOI: 10.1111/j.1574-695x.2011.00833.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
89 Sempértegui F, Díaz M, Mejía R, Rodríguez-mora OG, Rentería E, Guarderas C, Estrella B, Recalde R, Hamer DH, Reeves PG. Low Concentrations of Zinc in Gastric Mucosa are Associated with Increased Severity of Helicobacter pylori-Induced Inflammation. Helicobacter 2007;12. [DOI: 10.1111/j.1523-5378.2007.00476.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
90 Huang T, Zhou Y, Cheng AS, Yu J, To KF, Kang W. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors? Mol Cancer 2016;15:80. [PMID: 27938406 DOI: 10.1186/s12943-016-0566-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
91 Putoczki T, Ernst M. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol 2010;88:1109-17. [PMID: 20610798 DOI: 10.1189/jlb.0410226] [Cited by in Crossref: 97] [Cited by in F6Publishing: 84] [Article Influence: 8.8] [Reference Citation Analysis]
92 Wu Z, Wang H, Chu X, Chen J, Fang S. Association between FAS-1377 G/A polymorphism and susceptibility to gastric cancer: evidence from a meta-analysis. Tumour Biol 2013;34:2147-52. [PMID: 23636796 DOI: 10.1007/s13277-013-0747-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
93 Stemmermann GN, Nomura AMY. The relation of pepsinogen group II (PGII) expression to intestinal metaplasia and gastric cancer: Pepsinogen expression in gastric cancer. Histopathology 2006;49:45-51. [DOI: 10.1111/j.1365-2559.2006.02446.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
94 Hwang YJ, Kim N, Lee HS, Lee JB, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018;47:380-390. [PMID: 29193217 DOI: 10.1111/apt.14424] [Cited by in Crossref: 74] [Cited by in F6Publishing: 51] [Article Influence: 18.5] [Reference Citation Analysis]
95 Cabral MM, Mendes CM, Castro LP, Cartelle CT, Guerra J, Queiroz DM, Nogueira AM. Apoptosis in Helicobacter pylori gastritis is related to cagA status. Helicobacter. 2006;11:469-476. [PMID: 16961810 DOI: 10.1111/j.1523-5378.2006.00440.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
96 Perri F, Terracciano F, Gentile M, Merla A, Scimeca D, Zullo A. Role of interleukin polymorphisms in gastric cancer: "Pros and cons". World J Gastrointest Oncol. 2010;2:265-271. [PMID: 21160639 DOI: 10.4251/wjgo.v2.i6.265] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
97 Huang B, Song JH, Cheng Y, Abraham JM, Ibrahim S, Sun Z, Ke X, Meltzer SJ. Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene 2016;35:4927-36. [PMID: 26876208 DOI: 10.1038/onc.2016.25] [Cited by in Crossref: 62] [Cited by in F6Publishing: 72] [Article Influence: 12.4] [Reference Citation Analysis]
98 Jang JY, Chun HJ. Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer. World J Gastroenterol 2014;20:2760-4. [PMID: 24659868 DOI: 10.3748/wjg.v20.i11.2760] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Regalo G, Leutz A. Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia. EMBO Mol Med 2013;5:1154-64. [PMID: 23828660 DOI: 10.1002/emmm.201302834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
100 Mitani T, Shirasaka D, Aoyama N, Miki I, Morita Y, Ikehara N, Matsumoto Y, Okuno T, Toyoda M, Miyachi H, Yoshida S, Chayahara N, Hori J, Tamura T, Azuma T, Kasuga M. Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy. J Gastroenterol Hepatol 2008;23:e334-9. [PMID: 17725597 DOI: 10.1111/j.1440-1746.2007.05124.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
101 Peek RM Jr, Fiske C, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev. 2010;90:831-858. [PMID: 20664074 DOI: 10.1152/physrev.00039.2009] [Cited by in Crossref: 133] [Cited by in F6Publishing: 124] [Article Influence: 12.1] [Reference Citation Analysis]
102 Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol 2008;26:2876-82. [PMID: 18539967 DOI: 10.1200/JCO.2007.15.2603] [Cited by in Crossref: 128] [Cited by in F6Publishing: 67] [Article Influence: 9.8] [Reference Citation Analysis]
103 Kato K, Hasui K, Wang J, Kawano Y, Aikou T, Murata F. Homeostatic mass control in gastric non-neoplastic epithelia under infection of Helicobacter pylori: an immunohistochemical analysis of cell growth, stem cells and programmed cell death. Acta Histochem Cytochem. 2008;41:23-38. [PMID: 18636110 DOI: 10.1267/ahc.07021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
104 Ren J, Huang HJ, Gong Y, Yue S, Tang LM, Cheng SY. MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci. 2014;4:26. [PMID: 24855559 DOI: 10.1186/2045-3701-4-26] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
105 Mbulaiteye SM. Helicobacter Pylori associated global gastric cancer burden. Front Biosci 2009;Volume:1490. [DOI: 10.2741/3320] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
106 Sokic-Milutinovic A, Alempijevic T, Milosavljevic T. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol. 2015;21:11654-11672. [PMID: 26556993 DOI: 10.3748/wjg.v21.i41.11654] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
107 Cui Y, Zhou K, Strugatsky D, Wen Y, Sachs G, Zhou ZH, Munson K. pH-dependent gating mechanism of the Helicobacter pylori urea channel revealed by cryo-EM. Sci Adv 2019;5:eaav8423. [PMID: 30906870 DOI: 10.1126/sciadv.aav8423] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
108 Alandiyjany MN, Croxall NJ, Grove JI, Delahay RM. A role for the tfs3 ICE-encoded type IV secretion system in pro-inflammatory signalling by the Helicobacter pylori Ser/Thr kinase, CtkA. PLoS One. 2017;12:e0182144. [PMID: 28759055 DOI: 10.1371/journal.pone.0182144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
109 Sokolova O, Naumann M. Crosstalk Between DNA Damage and Inflammation in the Multiple Steps of Gastric Carcinogenesis. Curr Top Microbiol Immunol 2019;421:107-37. [PMID: 31123887 DOI: 10.1007/978-3-030-15138-6_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
110 Delahay RM, Croxall NJ, Stephens AD. Phylogeographic diversity and mosaicism of the Helicobacter pylori tfs integrative and conjugative elements. Mob DNA. 2018;9:5. [PMID: 29416569 DOI: 10.1186/s13100-018-0109-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
111 Hord NG, Fenton JI. Context is everything: Mining the normal and preneoplastic microenvironment for insights into the diet and cancer risk conundrum. Mol Nutr Food Res 2007;51:100-6. [DOI: 10.1002/mnfr.200600157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
112 Roussos A, Philippou N, Mantzaris GJ, Gourgoulianis KI. Respiratory diseases and Helicobacter pylori infection: is there a link? Respiration 2006;73:708-14. [PMID: 16763382 DOI: 10.1159/000093816] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
113 Rojas A, Araya P, Gonzalez I, Morales E. Gastric Tumor Microenvironment. Adv Exp Med Biol 2020;1226:23-35. [PMID: 32030673 DOI: 10.1007/978-3-030-36214-0_2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
114 Plieskatt JL, Deenonpoe R, Mulvenna JP, Krause L, Sripa B, Bethony JM, Brindley PJ. Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J 2013;27:4572-84. [PMID: 23925654 DOI: 10.1096/fj.13-232751] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 11.0] [Reference Citation Analysis]
115 El Hassan A, El Hassan L, Mudawi H, Gasim B, Own A, Elamin E, Ibn Ouf M, El Mekki Abdullah M, Fedail S. Malignant gastric tumors in Sudan. Hematology/Oncology and Stem Cell Therapy 2008;1:130-2. [DOI: 10.1016/s1658-3876(08)50044-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015;21:112-23. [PMID: 25574084 DOI: 10.3748/wjg.v21.i1.112] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
117 Battglia G, Lecis E, Donisi PM. Lymphoid follicule in gastric mucosa of Helicobacter pylori infected patients regression 6-12 months after eradication. Gut. 1995;37:76. [DOI: 10.1128/IAI.00801-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
118 Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012;4:156-169. [PMID: 22844547 DOI: 10.4251/wjgo.v4.i7.156] [Cited by in CrossRef: 251] [Cited by in F6Publishing: 209] [Article Influence: 27.9] [Reference Citation Analysis]
119 Hynes MJ, Huang KM, Huang EH. Review Paper: Implications of the “Cancer Stem Cell” Hypothesis on Murine Models of Colon Cancer and Colitis-associated Cancer. Vet Pathol 2009;46:819-35. [DOI: 10.1354/vp.08-vp-0172-h-rev] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
120 Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci 2020;21:E3115. [PMID: 32354115 DOI: 10.3390/ijms21093115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
121 Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014;34:771-785. [PMID: 25439276 DOI: 10.1016/j.cll.2014.08.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
122 Wang N, Yang J, Lu J, Qiao Q, Bao G, Wu T, He X. IL-17 gene polymorphism is associated with susceptibility to gastric cancer. Tumor Biol 2014;35:10025-30. [DOI: 10.1007/s13277-014-2255-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
123 Hayakawa Y, Fox JG, Gonda T, Worthley DL, Muthupalani S, Wang TC. Mouse models of gastric cancer. Cancers (Basel). 2013;5:92-130. [PMID: 24216700 DOI: 10.3390/cancers5010092] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
124 Cen G, Wu W. Association between tumor necrosis factor-alpha 857C/T polymorphism and gastric cancer: a meta-analysis. Tumour Biol. 2013;34:3383-3388. [PMID: 23821300 DOI: 10.1007/s13277-013-0910-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
125 Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Sekiyama A, Teshima-Kondo S. NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid Redox Signal 2006;8:1573-82. [PMID: 16987012 DOI: 10.1089/ars.2006.8.1573] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
126 Nisimova L, Wen S, Cross-Knorr S, Rogers AB, Moss SF, Chatterjee D. Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer. Crit Rev Oncog 2014;19:469-81. [PMID: 25597356 DOI: 10.1615/critrevoncog.2014012044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
127 Poh AR, O'Donoghue RJ, Ernst M, Putoczki TL. Mouse models for gastric cancer: Matching models to biological questions. J Gastroenterol Hepatol 2016;31:1257-72. [PMID: 26809278 DOI: 10.1111/jgh.13297] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
128 Ki M, Hwang M, Kim A, Lee E, Lee E, Lee M, Sung S, Kim S, Lee HS, Jeong K. Role of vacuolating cytotoxin VacA and cytotoxin-associated antigen CagA of Helicobacter pylori in the progression of gastric cancer. Mol Cell Biochem 2014;396:23-32. [DOI: 10.1007/s11010-014-2138-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
129 Zhao J, Wen S, Wang X, Zhang Z. Helicobacter pylori modulates cyclooxygenase-2 and 15-hydroxy prostaglandin dehydrogenase in gastric cancer. Oncol Lett 2017;14:5519-25. [PMID: 29113180 DOI: 10.3892/ol.2017.6843] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
130 Na YJ, Shim K, Joo YH, Kim S, Jung H, Jung S, Cho MS. RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma. Korean J Gastroenterol 2015;66:75. [DOI: 10.4166/kjg.2015.66.2.75] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
131 Judd LM, Ulaganathan M, Howlett M, Giraud AS. Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression. J Pathol. 2009;217:552-562. [PMID: 19097069 DOI: 10.1002/path.2479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
132 Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, Baik GH, Shibata W, Diprete B, Betz KS, Friedman R, Varro A, Tycko B, Wang TC. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19:257-272. [PMID: 21316604 DOI: 10.1016/j.ccr.2011.01.020] [Cited by in Crossref: 607] [Cited by in F6Publishing: 590] [Article Influence: 60.7] [Reference Citation Analysis]
133 Wang XY, Wang LL, Zheng X, Meng LN, Lyu B, Jin HF. Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats. World J Gastrointest Oncol 2016;8:305-13. [PMID: 26989466 DOI: 10.4251/wjgo.v8.i3.305] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
134 Laurence AD. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. Br J Haematol 2006;132:255-67. [PMID: 16409290 DOI: 10.1111/j.1365-2141.2005.05841.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
135 Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Nishida K, Teshima-Kondo S. Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin Immunopathol. 2008;30:315-327. [PMID: 18521607 DOI: 10.1007/s00281-008-0124-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
136 Tominaga K, Kawahara T, Sano T, Toida K, Kuwano Y, Sasaki H, Kawai T, Teshima-Kondo S, Rokutan K. Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radic Biol Med. 2007;43:1627-1638. [PMID: 18037128 DOI: 10.1016/j.freeradbiomed.2007.08.029] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
137 Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. J Cell Physiol. 2012;227:2686-2693. [PMID: 21898409 DOI: 10.1002/jcp.23013] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
138 Mannelli G, Gallo O. Cancer stem cells hypothesis and stem cells in head and neck cancers. Cancer Treat Rev 2012;38:515-39. [PMID: 22197808 DOI: 10.1016/j.ctrv.2011.11.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
139 Gao W, Xiong Y, Li Q, Yang H. Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics. Front Physiol 2017;8:508. [PMID: 28769820 DOI: 10.3389/fphys.2017.00508] [Cited by in Crossref: 150] [Cited by in F6Publishing: 126] [Article Influence: 37.5] [Reference Citation Analysis]
140 Ma L, Zeng J, Guo Q, Liang X, Shen L, Li S, Sun Y, Li W, Liu S, Yu H, Chen C, Jia J. Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis. Oncotarget 2016;7:11349-63. [PMID: 26870992 DOI: 10.18632/oncotarget.7239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
141 Takeshima E, Tomimori K, Teruya H, Ishikawa C, Senba M, D’Ambrosio D, Kinjo F, Mimuro H, Sasakawa C, Hirayama T. Helicobacter pylori-induced interleukin-12 p40 expression. Infect Immun. 2009;77:1337-1348. [PMID: 19179414 DOI: 10.1128/iai.01456-08] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
142 Satolli MA, Buffoni L, Spadi R, Roato I. Gastric cancer: The times they are a-changin'. World J Gastrointest Oncol 2015;7:303-16. [PMID: 26600930 DOI: 10.4251/wjgo.v7.i11.303] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
143 Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, Sung JJ. Dysregulation of cellular signaling in gastric cancer. Cancer Lett. 2010;295:144-153. [PMID: 20488613 DOI: 10.1016/j.canlet.2010.04.025] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 9.7] [Reference Citation Analysis]
144 Ito Y, Vela JL, Matsumura F, Hoshino H, Tyznik A, Lee H, Girardi E, Zajonc DM, Liddington R, Kobayashi M, Bao X, Bugaytsova J, Borén T, Jin R, Zong Y, Seeberger PH, Nakayama J, Kronenberg M, Fukuda M. Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One 2013;8:e78191. [PMID: 24312443 DOI: 10.1371/journal.pone.0078191] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
145 Rudnick JA, Kuperwasser C. Stromal biomarkers in breast cancer development and progression. Clin Exp Metastasis 2012;29:663-72. [DOI: 10.1007/s10585-012-9499-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
146 Burkitt MD, Pritchard DM. Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther. 2006;24:1305-1320. [PMID: 17059512 DOI: 10.1111/j.1365-2036.2006.03130.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 85] [Article Influence: 7.4] [Reference Citation Analysis]
147 Yu JY, Li L, Ma H, Liu K, Cheng X, Li YL, Song XL. Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumour Biol. 2013;34:3859-3863. [PMID: 23900678 DOI: 10.1007/s13277-013-0972-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
148 Wu WK, Sung JJ, To KF, Yu L, Li HT, Li ZJ, Chu KM, Yu J, Cho CH. The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells. J Cell Physiol. 2010;223:178-186. [PMID: 20054823 DOI: 10.1002/jcp.22026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
149 Cinque SM, Rocha GA, Correa-Oliveira R, Soares TF, Moura SB, Rocha AM, Nogueira AM, Cabral MM, Vieira LQ, Martins-Filho OA, Queiroz DM. The role of IFN-gamma and IL-4 in gastric mucosa inflammation associated with Helicobacter heilmannii type 1 infection. Braz J Med Biol Res 2006;39:253-61. [PMID: 16470313 DOI: 10.1590/s0100-879x2006000200012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
150 Ki M, Goo M, Park J, Hong I, Ji A, Han S, You S, Lee E, Kim A, Park S, Lee H, Kim S, Jeong K. Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-β1-induced inflammatory signaling. Lab Invest 2010;90:1507-16. [DOI: 10.1038/labinvest.2010.109] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
151 Muzaheed. Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors. ScientificWorldJournal 2020;2020:3018326. [PMID: 32765194 DOI: 10.1155/2020/3018326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
152 Peter S, Beglinger C. Helicobacter pylori and gastric cancer: the causal relationship. Digestion. 2007;75:25-35. [PMID: 17429205 DOI: 10.1159/000101564] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
153 Zhao D, Liu Z, Ding J, Li W, Sun Y, Yu H, Zhou Y, Zeng J, Chen C, Jia J. Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J Med Microbiol. 2010;59:259-265. [PMID: 19959630 DOI: 10.1099/jmm.0.014704-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
154 Kikuchi M, Nagata H, Watanabe N, Watanabe H, Tatemichi M, Hibi T. Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasia. BMC Gastroenterol 2010;10:65. [PMID: 20565818 DOI: 10.1186/1471-230X-10-65] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
155 Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer. 2007;7:645-658. [PMID: 17687385 DOI: 10.1038/nrc2192] [Cited by in Crossref: 454] [Cited by in F6Publishing: 389] [Article Influence: 32.4] [Reference Citation Analysis]
156 Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, Gumucio DL. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology. 2007;133:1989-1998. [PMID: 18054570 DOI: 10.1053/j.gastro.2007.09.031] [Cited by in Crossref: 112] [Cited by in F6Publishing: 104] [Article Influence: 8.6] [Reference Citation Analysis]
157 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol. 2014;20:13804-13819. [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
158 Kidane D, Chae WJ, Czochor J, Eckert KA, Glazer PM, Bothwell AL, Sweasy JB. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol 2014;49:116-39. [PMID: 24410153 DOI: 10.3109/10409238.2013.875514] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 12.3] [Reference Citation Analysis]
159 Lima VP, de Lima MA, André AR, Ferreira MV, Barros MA, Rabenhorst SH. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol 2008;14:884-91. [PMID: 18240345 DOI: 10.3748/wjg.14.884] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
160 Liu Z, Zhang X, Xu X, Chen L, Li W, Yu H, Sun Y, Zeng J, Jia J. RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer. Eur J Cell Biol. 2014;93:118-126. [PMID: 24636883 DOI: 10.1016/j.ejcb.2014.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
161 Choi S, Lim YJ, Park SK. Risk factor analysis for metaplastic gastritis in Koreans. World J Gastroenterol 2006;12:2584-7. [PMID: 16688806 DOI: 10.3748/wjg.v12.i16.2584] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
162 Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol. 2007;21:281-297. [PMID: 17382277 DOI: 10.1016/j.bpg.2007.02.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
163 Watari J, Ito C, Shimoda T, Tomita T, Oshima T, Fukui H, Das KM, Miwa H. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use. Sci Rep 2019;9:12559. [PMID: 31467363 DOI: 10.1038/s41598-019-49069-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
164 Takeshima E, Tomimori K, Kawakami H, Ishikawa C, Sawada S, Tomita M, Senba M, Kinjo F, Mimuro H, Sasakawa C. NF-kappaB activation by Helicobacter pylori requires Akt-mediated phosphorylation of p65. BMC Microbiol. 2009;9:36. [PMID: 19216748 DOI: 10.1186/1471-2180-9-36] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
165 Saito Y, Suzuki H, Tsugawa H, Suzuki S, Matsuzaki J, Hirata K, Hibi T. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology. 2011;140:189-198. [PMID: 20801118 DOI: 10.1053/j.gastro.2010.08.044] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
166 Sabbagh P, Mohammadnia-afrouzi M, Javanian M, Babazadeh A, Koppolu V, Vasigala VR, Nouri HR, Ebrahimpour S. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis 2019;38:55-66. [DOI: 10.1007/s10096-018-3414-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
167 Worthley DL, Ruszkiewicz A, Davies R, Moore S, Nivison-Smith I, Bik To L, Browett P, Western R, Durrant S, So J. Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells. 2009;27:1463-1468. [PMID: 19492298 DOI: 10.1002/stem.63] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
168 Yuan T, Ni Z, Han C, Min Y, Sun N, Liu C, Shi M, Lu W, Wang N, Du F, Wu Q, Xie N, Shi Y. SOX2 interferes with the function of CDX2 in bile acid-induced gastric intestinal metaplasia. Cancer Cell Int 2019;19:24. [PMID: 30733645 DOI: 10.1186/s12935-019-0739-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]